ERBB2 and glioblastoma: (44) revealed that the infusion of autologous HER2-specific embedded CAR-modified virus-specific T cells (VST) is safe and is potentially linked to clinical benefit in patients with progressive GBM (ClinicalTrials.gov, NCT01109095).